News tagged with inhaler
FDA approves once-a-day inhaler from Glaxo
The Food and Drug Administration says it has approved a new once-a-day inhaler drug from GlaxoSmithKline for patients with chronic lung disease.
Medications
May 10, 2013 |
not rated yet |
0
ATS publishes clinical practice guidelines on exercise-induced bronchoconstriction
The American Thoracic Society has released new official clinical practice guidelines on the diagnosis and management of exercise-induced bronchoconstriction (EIB), the acute airway narrowing that occurs as a result of exercise.
Diseases, Conditions, Syndromes
May 01, 2013 |
4 / 5 (1) |
0
US panel backs inhaler drug for lung disease
A panel of U.S. respiratory experts voted Wednesday in favor of approving an experimental inhaler drug from GlaxoSmithKline and Theravance for treating chronic lung disease.
Medications
Apr 17, 2013 |
not rated yet |
0
Breathing problem sometimes misdiagnosed in athletes
(HealthDay)—A vocal cord problem that restricts athletes' breathing is often misdiagnosed as exercise-induced asthma, a small new study suggests.
Diseases, Conditions, Syndromes
Apr 12, 2013 |
not rated yet |
0
Italy bans minors from buying electronic cigarettes
Italy on Tuesday announced plans to raise the legal limit for buying electronic cigarettes to 18 years from a previous 16, citing the high dose of nicotine inhaled when using the smokeless product.
Health
Apr 02, 2013 |
not rated yet |
0
Inhaler approved for cystic fibrosis patients
(HealthDay)—The TOBI Podhaler (tobramycin inhalation powder) has been approved by the U.S. Food and Drug Administration to treat cystic fibrosis patients infected with Pseudomonas aeruginosa, a bacterium that can damage ...
Medications
Mar 25, 2013 |
not rated yet |
0
Single combo inhaler beats standard rx in asthma
(HealthDay)—Maintenance and reliever therapy with a single inhaled corticosteroid plus a rapid-onset, long-acting, β2 agonist (formoterol) seems beneficial for patients with asthma, according to two stu ...
Diseases, Conditions, Syndromes
Mar 05, 2013 |
not rated yet |
0
Should caffeine be a regulated substance?
Caffeine-related toxicity, deaths, and near-deaths are an undeniable fact. In Sweden, for example, four people died as a result of confirmed caffeine-related causes in one year. Yet caffeine use continues to grow, including ...
Health
Feb 26, 2013 |
3 / 5 (2) |
0
Cost of medication and stigma leading asthma sufferers to risk health
The high cost of medication, stigmatisation and poor acceptance of their condition are causing young adults to take a dangerous approach to managing their asthma, according to new research published today ...
Diseases, Conditions, Syndromes
Feb 20, 2013 |
not rated yet |
0
Added benefit of aclidinium bromide is not proven
The drug aclidinium bromide (trade names Eklira, Bretaris) has been approved since October 2012 for widening the narrowed airways of adults with chronic-obstructive pulmonary disease (COPD). The German Institute for Quality ...
Medications
Jan 30, 2013 |
not rated yet |
0
FDA panel backs long-acting Boehringer inhaler
(AP)—A panel of federal health experts is overwhelmingly recommending approval for a long-acting inhaler to treat people suffering from chronic lung disease.
Medications
Jan 29, 2013 |
not rated yet |
0
Gene testing asthmatic children could lead to better treatment
(Medical Xpress)—Testing asthmatic children for a specific gene could prevent their condition worsening, according to new research by scientists in Dundee and Brighton.
Inflammatory disorders
Jan 08, 2013 |
not rated yet |
0
Why are kids in asthma hotspots in NYC more likely to visit the ER? Exercise may be a factor
Asthmatic children in New York City neighborhoods with high rates of asthma make many more visits to the emergency room (ER) than those who live in other parts of the city. While socioeconomic factors such as lack of adequate ...
Pediatrics
Dec 17, 2012 |
not rated yet |
0
1990s trial gave early danger signs for asthma drugs
The troubled history of asthma drugs known as long-acting beta-agonists goes back to the 1990s when a large clinical trial in Great Britain of the GlaxoSmithKline drug Serevent produced disturbing results.
Medications
Nov 25, 2012 |
not rated yet |
0
Taiwan prosecutor: Cancer patient set deadly fire
(AP)—A nursing home resident upset about being ill with cancer confessed to setting a fire that killed 12 fellow patients, most of them bedridden and too frail to escape, authorities in Taiwan said.
Health
Oct 24, 2012 |
not rated yet |
0
Inhaler
An inhaler or puffer is a medical device used for delivering medication into the body via the lungs. It is mainly used in the treatment of asthma and Chronic Obstructive Pulmonary Disease (COPD). Zanamivir (Relenza), used to treat influenza, must be administered via inhaler. To reduce deposition in the mouth and throat, and to reduce the need for precise synchronization of the start of inhalation with actuation of the device, MDIs are sometimes used with a complementary spacer or holding chamber device.
For more information about Inhaler, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
